23 Mai 2017 Jahr - Pembrolizumab Approved
Beschreibung:
FDA approved Pembrolizumab for specific tumors which have been identified to have a biomarker referred to as microsatellite instability-high. Meant for those who have undergone other treatments, and with no other alternatives.
Zugefügt zum Band der Zeit:
Datum:
~ 8 years and 4 months ago